Event Date/Time: May 30, 2012 End Date/Time: May 31, 2012
Report as Spam


Next Generation Antibody Manufacturing will address the latest developments in mAb processing and tackle the new manufacturing challenges you are facing with your innovative products. This meeting will help you maximize antibody titers, adapt and improve your product recovery methods and streamline process development. With expert talks from Genentech, Millennium, Genzyme, Abbott and many more this is your best opportunity to get up to speed with the cutting edge technologies, processes and maximize your yield.

Top sessions not to be missed:

- Genentech describe how they are aligning people, technology and work processes to achieve reliable next generation antibody manufacturing operations

- Genzyme and Merck will reveal their tools for using continuous processing to minimize production down time

- Insights into the challenges in bispecific antibody expression and purification with F-star, NovImmune and Macrogenics

- See how Merrimack are assaying bispecific metabolites produced during CHO expression processes

- Progenics will explain how they are tackling the challenge of conducting robust stability monitoring and routine lot-release testing for their ADC and, Millennium and Abbott will describe their perspectives on ADC CMC CQAs

- Imclone’s highlight how their CMC project management team has dramatically improved overall manufacturing efficiency

- Hear Roche and EMD Serono discuss the optimal approaches to cell line development for mAbs and engineered antibodies

For more information on what will be covered in the meeting, please download the final agenda now: www.antibody-manufacturing.com

To book your place, simply visit the website, email info@hansonwade.com or call us on +1 212 37 5898